Medifast (MED) Reports Q4 Loss, Beats Revenue Estimates

分组1 - Medifast reported a quarterly loss of $0.55 per share, better than the Zacks Consensus Estimate of a loss of $0.76, representing an earnings surprise of +27.63% [1] - The company posted revenues of $75.1 million for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 6.05%, but down from $119 million year-over-year [2] - Medifast has surpassed consensus EPS estimates two times and revenue estimates three times over the last four quarters [2] 分组2 - The stock's immediate price movement will depend on management's commentary during the earnings call and future earnings expectations [3][4] - Medifast shares have increased by about 0.8% since the beginning of the year, while the S&P 500 has declined by 0.1% [3] - The current consensus EPS estimate for the coming quarter is -$0.12 on revenues of $67.12 million, and -$0.57 on revenues of $228.38 million for the current fiscal year [7] 分组3 - The Zacks Industry Rank indicates that the Food - Miscellaneous sector is in the bottom 16% of over 250 Zacks industries, which may impact stock performance [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that tracking these revisions can be beneficial for investors [5][6] - Medifast currently holds a Zacks Rank 2 (Buy), indicating expectations for the stock to outperform the market in the near future [6]